Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Denali Therapeutics (D2NL34.SA) Q2 2025 Earnings
D2NL34.SA
6
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.66
-4.24
-3.81
-3.38
Details
Expected EPS
-3.9795520541000005
Actual EPS
-4.456686
Surprise EPS
-0.48
Surprise Percent
+11.99%
Description
Denali Therapeutics (D2NL34.SA) has reported earnings of -4.456686 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login